Skip to content
1st Counsel – Lifestyle
Author:
ALTRUIST BIOLOGICS
Altruist Biologics’ Integrated CMC Platform Supports NMPA Acceptance of NDA for Localized Manufacturing of Multinational Client’s Biologic
October 29, 2026
Altruist Biologics’ Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market
September 22, 2026
Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA
September 14, 2026
Altruist Biologics Completes First Commercial PPQ Campaign of its 20,000L Production Line at the Hangzhou Site
August 5, 2026
Altruist Biologics’ Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production
July 8, 2026